SNORA72: A Potential Drug Target and Biomarker (G26775)

Target Name: SNORA72

NCBI ID: G26775

SNORA72

Other Name(s): small nucleolar RNA, H/ACA box 72 | RNU72 | Small nucleolar RNA, H/ACA box 72 | U72

SNORA72: A Potential Drug Target and Biomarker

Small nucleolar RNA (snRNA), also known as H/ACA box RNA, is a non-coding RNA molecule that plays a crucial role in the regulation of gene expression in various organisms, including humans. H/ACA box RNA is a subclass of snRNA that is characterized by the presence of a specific open reading frame (ORF), which is typically located upstream of a protein-coding gene. One of the well-known functions of H/ACA box RNA is to interact with the protein-coding genes, which are responsible for encoding the proteins that perform various cellular functions.

SNORA72 is a specific H/ACA box RNA that has been identified in various cellular studies as a potential drug target and biomarker. The H/ACA box 72 is located in the 5'-end of the RNA molecule and has a length of 72 nucleotides. It is characterized by the presence of a specific base in its first exon, which is different from the standard A or U base that is found in most H/ACA box RNAs. The specific base that is found in the first exon of SNORA72 is G, which is unique among H/ACA box RNAs.

The H/ACA box 72 gene is located on chromosome 18 at position 662.3 and has a protein coding gene that encodes a protein with a calculated molecular mass of 41.1 kDa. The protein encoded by the H/ACA box 72 gene is involved in various cellular processes, including cell adhesion, migration, and the regulation of the cell cycle. It is also involved in the regulation of gene expression and has been implicated in the development and progression of various diseases, including cancer.

SNORA72 has been shown to play a role in the regulation of cellular processes by interacting with the protein-coding genes. Several studies have demonstrated that SNORA72 can interact with various protein-coding genes and that this interaction can lead to the regulation of gene expression. For example, studies have shown that SNORA72 can interact with the protein-coding gene PDGF-伪 and that this interaction can lead to the regulation of gene expression involved in cell proliferation and survival.

In addition to its role in gene regulation, SNORA72 has also been shown to play a role in the regulation of cellular processes by interacting with the non-coding RNA molecule let-7. Let-7 is a non-coding RNA molecule that is located upstream of the H/ACA box 72 gene and has been shown to play a role in the regulation of gene expression. Studies have shown that SNORA72 can interact with Let-7 and that this interaction can lead to the regulation of gene expression involved in cell adhesion and migration.

SNORA72 has also been shown to play a role in the regulation of cellular processes by interacting with the protein-coding gene TGF-β. TGF-β is a well-known protein-coding gene that is involved in the regulation of cellular processes, including cell growth, differentiation, and survival. Studies have shown that SNORA72 can interact with TGF-β and that this interaction can lead to the regulation of gene expression involved in cell proliferation and survival.

SNORA72 has been shown to play a role in the regulation of cellular processes by interacting with the protein-coding gene NF-kappa-B. NF-kappa-B is a well-known protein-coding gene that is involved in the regulation of cellular processes, including inflammation, stress, and survival. Studies have shown that SNORA72 can interact with NF-kappa-B and that this interaction can lead to the regulation of gene expression involved in

Protein Name: Small Nucleolar RNA, H/ACA Box 72

The "SNORA72 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORA72 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets